NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY – Get Free Report) was the recipient of a significant drop in short interest in the month of February. As of February 28th, there was short interest totalling 89,000 shares, a drop of 19.2% from the February 13th total of 110,200 shares. Approximately 2.1% of the shares of the company are sold short. Based on an average daily trading volume, of 234,600 shares, the short-interest ratio is currently 0.4 days.
NovaBay Pharmaceuticals Trading Up 2.3 %
Shares of NYSEAMERICAN NBY opened at $0.64 on Tuesday. NovaBay Pharmaceuticals has a 1-year low of $0.36 and a 1-year high of $9.08. The firm has a market capitalization of $2.71 million, a price-to-earnings ratio of -0.06 and a beta of 2.82.
About NovaBay Pharmaceuticals
See Also
- Five stocks we like better than NovaBay Pharmaceuticals
- Stock Average Calculator
- Can TikTok Stock Picks Really Make You Rich?
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- The “Quality” Rotation: Back to Basics Investing
- How to Calculate Return on Investment (ROI)
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for NovaBay Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovaBay Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.